In the PPARγ/PTEN/AKT signaling pathway, upregulation of PPARγ and PTEN proteins inhibits the AKT-activated cascade response, as demonstrated in both pancreatic cancer [65] and bladder cancer [66]. The gene discussed is AKT1; the disease is urinary bladder carcinoma.